TLM Utility Nav

HCV Elimination: Past, Present and Future, 2013, 2024 and 2030

Nov 15 2024
Convention Center: Room 11
2:00 PM - 3:30 PM

Description

10 years after HCV treatment 2nd Gen DAAs broke the warehouse, where are we now? What have we learned? and can we actually End Hep C by 2030? HCV elimination: different approaches to elimination around the country, past, present and future.

Journey Maps

Presentations

2:00 PM - 2:15 PM
Nov 15 2024
San Diego, CA

Ten Years since DAAs: Achievements and Opportunities

Mark Sulkowski, MD, FAASLD, Presenter
Patient Program
2:15 PM - 2:30 PM
Nov 15 2024
San Diego, CA

Moving the Needle: Harm Reduction Best Practices in HCV Elimination

Clayton Ruley, Presenter
Patient Program
2:30 PM - 2:45 PM
Nov 15 2024
San Diego, CA

Local HCV Elimination Efforts: End Hep C SD

Rick Jaenisch, Presenter
Patient Program
2:45 PM - 3:00 PM
Nov 15 2024
San Diego, CA

Panel Discussion

George N. Ioannou, MD, FAASLD, Moderator
Patient Program

Objectives

  • A better understanding of HCV Elimination efforts connected components, History, and populations that require more attention to achieve elimination: incarcerated people, PWUD, (and AI/AN or International Success)
  • A key takeaway from this session should be to spur interest in helping patients with HCV see themselves as part of a global effort working together, not only are their lives improved, but the world for it. With stigma as strong as it is, a message of hope is only as strong as the messenger, a message of hope and belonging is stronger and helps at eroding stigma via self-esteem and a perception of a stronger "invisible" support network.
Chair

Rick Jaenisch

Chair

George N. Ioannou, MD, FAASLD

University of Washington Medical Center